Presentations Aug 09, 2023 Corporate Presentation Q3 2023 Jun 07, 2023 Lunresertib (RP-6306) Initial Phase 1 Data Apr 18, 2023 AACR 2023 – Plenary Presentation Jun 01, 2022 Worldwide License and Collaboration Agreement with Roche for camonsertib (RP-3500) Apr 11, 2022 AACR 2022 Mar 08, 2022 ESMO TAT 2022 Presentation Oct 08, 2021 Preliminary Phase 1 Data From Ongoing First-in-Human Phase 1/2 TRESR Study of RP-3500